Charles H Adler Selected Research

3 Progressive Supranuclear Palsy

6/2014

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles H Adler Research Topics

Disease

52	Parkinson Disease (Parkinson's Disease) 09/2021 - 02/2002
19	Dementia (Dementias) 01/2022 - 07/2009
14	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2009
14	Synucleinopathies 01/2022 - 11/2012
8	Cognitive Dysfunction 01/2022 - 07/2009
7	Parkinsonian Disorders (Parkinsonism) 01/2021 - 06/2008
7	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 04/2008
7	Torticollis (Wryneck) 10/2019 - 09/2003
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2012
6	Disease Progression 01/2021 - 05/2014
5	Deglutition Disorders (Dysphagia) 05/2017 - 06/2012
4	Amyloid Plaque 01/2021 - 01/2012
4	Tremor (Tremors) 12/2016 - 09/2004
4	Pain (Aches) 03/2016 - 10/2008
3	COVID-19 01/2022 - 01/2021
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2019
3	Multiple System Atrophy 09/2021 - 01/2021
3	Dysphonia (Spastic Dysphonia) 11/2015 - 09/2004
3	Dystonia (Limb Dystonia) 09/2010 - 01/2002
2	Chronic Traumatic Encephalopathy 12/2021 - 01/2021
2	Encephalitis (Encephalitis, Rasmussen) 02/2021 - 01/2017
2	Pneumonia (Pneumonitis) 01/2021 - 02/2013
2	Psychotic Disorders (Schizoaffective Disorder) 10/2019 - 12/2018
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019 - 01/2018
2	Ganglion Cysts (Ganglion) 10/2018 - 01/2018
2	Dyskinesias (Dyskinesia) 03/2018 - 02/2002
2	Movement Disorders (Movement Disorder) 03/2018 - 09/2010
2	Inflammation (Inflammations) 01/2015 - 02/2011
2	Restless Legs Syndrome (Restless Legs) 10/2011 - 08/2006
2	Myoclonus (Nocturnal Myoclonus) 07/2011 - 09/2010
2	Hemifacial Spasm 09/2010 - 07/2007
1	Cerebral Infarction 02/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Heart Failure 01/2021
1	Obesity 01/2021
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2021
1	Gliosis 01/2021
1	Muscle Cramp (Cramp) 11/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Corticobasal Degeneration 01/2019
1	Carotid Artery Diseases 01/2019
1	Orthostatic Hypotension (Postural Hypotension) 08/2018
1	Pure Autonomic Failure 08/2018
1	Hypotension (Low Blood Pressure) 08/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Brain Diseases (Brain Disorder) 01/2018

Drug/Important Bio-Agent (IBA)

29	SynucleinsIBA 01/2022 - 02/2011
22	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2012
12	alpha-SynucleinIBA 01/2020 - 06/2008
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2012
8	Type A Botulinum Toxins (Botox)FDA Link 10/2019 - 01/2002
7	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 08/2013
6	Proteins (Proteins, Gene)FDA Link 02/2021 - 02/2011
5	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2020 - 04/2008
4	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2012
4	Botulinum Toxins (Botulinum Toxin)IBA 03/2016 - 09/2003
3	florbetapirIBA 01/2021 - 04/2014
3	Retinaldehyde (Retinal)IBA 11/2020 - 06/2014
3	Pharmaceutical PreparationsIBA 05/2017 - 02/2013
2	CytokinesIBA 01/2022 - 01/2015
2	Biological ProductsIBA 12/2021 - 04/2014
2	TESIBA 12/2021 - 01/2021
2	Serine (L-Serine)FDA Link 01/2021 - 06/2014
2	Antipsychotic Agents (Antipsychotics)IBA 10/2019 - 12/2018
2	pimavanserinIBA 10/2019 - 12/2018
2	Amyloid beta-PeptidesIBA 01/2019 - 01/2009
2	Formaldehyde (Formol)FDA Link 01/2019 - 03/2014
2	ParaffinIBA 01/2019 - 03/2014
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018 - 10/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016 - 01/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2010 - 07/2009
2	Cholinergic Agents (Cholinergics)IBA 09/2010 - 07/2009
2	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2010 - 07/2009
2	Levodopa (L Dopa)FDA LinkGeneric 07/2009 - 09/2007
2	rimabotulinumtoxinB FDA Link 07/2007 - 09/2004
1	Apolipoprotein E4IBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	neuromelaninIBA 01/2021
1	florbenazine F 18IBA 01/2021
1	RadiopharmaceuticalsIBA 01/2021
1	Propranolol (Inderal)FDA LinkGeneric 11/2020
1	Neurofilament ProteinsIBA 01/2020
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2019
1	AnticoagulantsIBA 01/2019
1	Quetiapine Fumarate (Seroquel)FDA Link 12/2018
1	Clozapine (Clozaril)FDA LinkGeneric 12/2018
1	melanopsinIBA 10/2018
1	Enhancer RNAsIBA 10/2018
1	hydroxide ionIBA 08/2018
1	Amantadine (Aman)FDA LinkGeneric 03/2018

Therapy/Procedure

8	Therapeutics 01/2021 - 02/2002
3	Deep Brain Stimulation 01/2018 - 08/2006
2	Denervation 01/2020 - 08/2013
2	Injections 09/2004 - 01/2002
1	Sympathectomy (Sympathectomies) 01/2020